{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Morfill C"],"funding":["Cancer Research UK","FP7 People: Marie-Curie Actions","Medical Research Council","Imperial College London","Royal Society of Chemistry","Wellcome Trust","Division of Intramural Research, National Institute of Allergy and Infectious Diseases","Engineering and Physical Sciences Research Council","Michael J. Fox Foundation for Parkinson&apos;s Research"],"pagination":["47445-47460"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9614720"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["14(42)"],"pubmed_abstract":["A challenge in neurology is the lack of efficient brain-penetrable neuroprotectants targeting multiple disease mechanisms. Plasmonic gold nanostars are promising candidates to deliver standard-of-care drugs inside the brain but have not been trialed as carriers for neuroprotectants. Here, we conjugated custom-made peptide dendrimers (termed H3/H6), encompassing motifs of the neurotrophic S100A4-protein, onto star-shaped and spherical gold nanostructures (H3/H6-AuNS/AuNP) and evaluated their potential as neuroprotectants and interaction with neurons. The H3/H6 nanostructures crossed a model blood-brain barrier, bound to plasma membranes, and induced neuritogenesis with the AuNS, showing higher potency/efficacy than the AuNP. The H3-AuNS/NP protected neurons against oxidative stress, the H3-"],"journal":["ACS applied materials & interfaces"],"pubmed_title":["Nanostars Carrying Multifunctional Neurotrophic Dendrimers Protect Neurons in Preclinical In Vitro Models of Neurodegenerative Disorders."],"pmcid":["PMC9614720"],"funding_grant_id":["11713","EP/L015277/1","R01AI145436","P627049","FC0010218"],"pubmed_authors":["Kiryushko D","Fernando NK","Pinna A","Pankratova S","Klosowski M","Wilkinson RJ","Machado P","Talamona F","Morfill C","Xie F","Regoutz A","Porter AE","Fleck RA"],"additional_accession":[]},"is_claimable":false,"name":"Nanostars Carrying Multifunctional Neurotrophic Dendrimers Protect Neurons in Preclinical In Vitro Models of Neurodegenerative Disorders.","description":"A challenge in neurology is the lack of efficient brain-penetrable neuroprotectants targeting multiple disease mechanisms. Plasmonic gold nanostars are promising candidates to deliver standard-of-care drugs inside the brain but have not been trialed as carriers for neuroprotectants. Here, we conjugated custom-made peptide dendrimers (termed H3/H6), encompassing motifs of the neurotrophic S100A4-protein, onto star-shaped and spherical gold nanostructures (H3/H6-AuNS/AuNP) and evaluated their potential as neuroprotectants and interaction with neurons. The H3/H6 nanostructures crossed a model blood-brain barrier, bound to plasma membranes, and induced neuritogenesis with the AuNS, showing higher potency/efficacy than the AuNP. The H3-AuNS/NP protected neurons against oxidative stress, the H3-","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Oct","modification":"2025-04-04T09:42:22.966Z","creation":"2025-04-04T09:42:22.966Z"},"accession":"S-EPMC9614720","cross_references":{"pubmed":["36218307"],"doi":["10.1021/acsami.2c14220"]}}